Business
Notice of Q1 FY22 Results
Notice of Q1 FY22 Results.
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 2978U\n Renalytix PLC\n 02 December 2021\n \n \n \n \n \n \n \n Renalytix plc\n \n \n (\"Renalytix\" or the \"Company\")\n \n \n \n \n \n Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7\n \n \n \n \n \n \n LONDON and SALT LAKE CITY, December 2, 2021\n \n -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Company will release first quarter fiscal year 2022 financial results on Tuesday, December 7, 2021, before market open. The Company will host a corresponding conference call and live webcast to discuss the financial results and key topics including business strategy, partnerships and regulatory and reimbursement processes, at 8:30 a.m. (EST) / 1:30 p.m. (GMT).\n \n \n \n \n \n \n Conference Call Details:\n \n \n \nUS/Canada Participant Toll-Free Dial-In Number: (833) 614-1551\nUS/Canada Participant International Dial-In Number: (914) 987-7290\nUnited Kingdom International Dial-In Number: 0800 0288 438\nUnited Kingdom Local Dial-In Number: 0203 1070 289\nConference ID:2495524\n \n \n \n \n \n \n Webcast Registration link: \n \n \n https://edge.media-server.com/mmc/p/2s8cwr7x\n \n \n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n Renalytix plc \n \n \n \n \n \n www.renalytix.com\n \n \n \n \n \n \n \n James McCullough, CEO \n \n \n \n \n Via Walbrook PR \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel (Nominated Adviser, \n \n \n Joint Broker\n \n \n )\n \n \n \n \n \n Tel: 020 7710 7600\n \n \n \n \n \n \n Alex Price / \n Nicholas Moore\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank plc (Joint Broker)\n \n \n \n \n Tel: 020 7597 4000\n \n \n \n \n \n \n Gary Clarence / Daniel Adams\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n \n Tel: 020 7933 8780 \n \n or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McManus / Lianne Cawthorne\n \n \n \n \n Mob: 07980 541 893 / 07584 391 303\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n CapComm Partners\n \n \n \n \n \n \n \n \n \n \n \n \n \n Peter DeNardo\n \n \n \n \n \n \n \n \n Tel: 415-389-6400\n...